These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 5398121)

  • 1. [The serotonin level in the blood and urinary excretion of 5-oxy-indoleacetic acid in women during pregnancy].
    Khoreva ZP
    Akush Ginekol (Mosk); 1969 Sep; 45(9):10-2. PubMed ID: 5398121
    [No Abstract]   [Full Text] [Related]  

  • 2. [Levels of indolamines (serotonin, melatonin) and the excretion of 5-indolacetic acid in the urine of healthy children].
    Dadambaev ET
    Pediatr Akus Ginekol; 1975; (5):7-8. PubMed ID: 1208176
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood serotonin (5-HT) level and diurnal excretion of hydroxyindoleacetic acid (HIAA) in chronic liver diseases].
    Pokora J; Słomka M; Celinski K
    Pol Arch Med Wewn; 1980 Jun; 63(6):537-42. PubMed ID: 7190689
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on urinary 5-hydroxyindoleacetic acid (5-HIAA) excretion in infancy and children].
    Nakamura Y
    Kumamoto Igakkai Zasshi; 1970 Mar; 44(3):194-207. PubMed ID: 4246879
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serotonin and 5-oxyindoleacetic acid content in patients with pulmonary tuberculosis during treatment].
    Maslennikova NK; Tsukernik AV; Shevchenko VV
    Probl Tuberk; 1973; 51(11):26-9. PubMed ID: 4774890
    [No Abstract]   [Full Text] [Related]  

  • 6. The urinary excretion of 5-hydroxyindoleacetic acid after the oral administration of serotonin in various disease states.
    DONALDSON RM; ZAIDMAN I; GRAY SJ
    Gastroenterology; 1960 Jun; 38():937-41. PubMed ID: 13817484
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serotonin, blood platelets, and migraine. A connection?].
    Sjaastad O
    Nord Med; 1971 May; 85(21):669. PubMed ID: 5581418
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the urinary elimination of 5-hydroxyindo-lacetic acid in man. I. Behavior of the urinary elimination of 5-hydroxyindolacetic acid after serotonin loading by intramuscular route in healthy and hepatopathic subjects].
    PASSERI M
    G Clin Med; 1961 Jan; 42():67-77. PubMed ID: 13733173
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the urinary elimination of 5-hydroxyindo-lacetic acid in man. II. Progress of the urinary elimination of 5-hydroxyindolacetic acid after oral and intramuscular loading with serotonin in normal subjects and icteric patients].
    PASSERI M
    G Clin Med; 1961 Feb; 42():137-45. PubMed ID: 13733174
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serotonin metabolism in dumping syndrome].
    Sveshnikov AI; Stoilov LD
    Sov Med; 1968 Oct; 31(10):24-8. PubMed ID: 5744962
    [No Abstract]   [Full Text] [Related]  

  • 11. [Changes in serotonin metabolism in patients with hypertension].
    Sabirova RKh; Farkhutdinov RG
    Kardiologiia; 1972 Aug; 12(8):19-22. PubMed ID: 4642630
    [No Abstract]   [Full Text] [Related]  

  • 12. Biogenic amines derived from tryptophan in systemic and cutaneous scleroderma.
    Stachów A; Jabłońska S; Skiendzielewska A
    Acta Derm Venereol; 1979; 59(1):1-5. PubMed ID: 84460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serotonin metabolism in diseases of the large intestine].
    Bilich IL; Smirnov IuV
    Ter Arkh; 1975; 47(5):138-41. PubMed ID: 1162613
    [No Abstract]   [Full Text] [Related]  

  • 14. [Excretion of 5-oxiindolacetic acid and xanthurenic acid in diabetes mellitus].
    Geller LI; Kozlova ZP; Kontsevaia NG
    Probl Endokrinol (Mosk); 1970; 16(3):30-4. PubMed ID: 5513842
    [No Abstract]   [Full Text] [Related]  

  • 15. [Metoclopramide does not influence urinary elimination of N-methylnicotinamide and 5-OH-indoleacetic acid].
    Grillo G; Luvarà A; Rovere F
    Acta Vitaminol Enzymol; 1968; 22(3):99-103. PubMed ID: 4239849
    [No Abstract]   [Full Text] [Related]  

  • 16. [The urinary determination of a catabolite of serotonin (5-hydroxyindolacetic acid) in coronary insufficiency with or without myocardial infarct].
    ANGELINO PF; PELLEGRINI A; CROLLE G; PAGANO PG; TARTARA D
    Minerva Med; 1961 Jun; 52():2193-6. PubMed ID: 13683555
    [No Abstract]   [Full Text] [Related]  

  • 17. [Dynamics of elimination of 5-oxy-indoleacetic acid from urine in patients with myasthenia].
    Vaisfel'd IL; Kolomenskaia EA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1965; 65(8):1152-7. PubMed ID: 4288145
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on the level of urinary 5-hydroxyindolacetic acid in women with and without previous psychoprophylactic preparation in labor].
    CHOJECKA B; GOLISZEK J; KURZEPA S; LESINSKI J; SAMOJLIK E
    Pol Tyg Lek; 1961 Mar; 16():383-5. PubMed ID: 13693239
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diurnal changes in the urinary excretion of 5-hydroxy-indol-acetic acid in normal subjects].
    Fogari R; Goi C; Corradi L
    Arch Sci Med (Torino); 1974; 131(2):57-9. PubMed ID: 4423880
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dynamics of the serotonin content and melatonin and 5-hydroxy-indoleacetic acid excretion at the end of pregnancy, during normal labor and in labor anomalies].
    Demidenko DI
    Vopr Okhr Materin Det; 1976 Nov; 21(11):63-7. PubMed ID: 1007130
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.